Novel function of the unique N-terminal region of RUNX1c in B cell growth regulation

Nucleic Acids Research

Volumn 41, Issue 3, 2013, Pages 1555-1568

  Brady, Gareth ^a   Elgueta Karstegl, Claudio ^a   Farrell, Paul J ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN RUNX1B; PROTEIN RUNX1C; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ETV6; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL CYCLE REGULATION; CELL GROWTH; CONTROLLED STUDY; EMBRYO; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN VERSUS ANIMAL COMPARISON; LYMPHOBLASTOID CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

AMINO ACID MOTIFS; ANIMALS; B-LYMPHOCYTES; CELL LINE; CELL PROLIFERATION; CORE BINDING FACTOR ALPHA 2 SUBUNIT; CORE BINDING FACTOR BETA SUBUNIT; DNA; HUMANS; MICE; ONCOGENE PROTEINS, FUSION; PEPTIDES;

EID: 84873689014     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gks1273     Document Type: Article

References (43)

1. Cameron,E.R. and Neil,J.C. (2004) The Runx genes: lineage-specific oncogenes and tumor suppressors. Oncogene, 23, 4308-4314.
2. de Bruijn,M.F. and Speck,N.A. (2004) Core-binding factors in hematopoiesis and immune function. Oncogene, 23, 4238-4248.
3. Levanon,D. and Groner,Y. (2004) Structure and regulated expression of mammalian RUNX genes. Oncogene, 23, 4211-4219.
4. Levanon,D., Bettoun,D., Harris-Cerruti,C., Woolf,E., Negreanu,V., Eilam,R., Bernstein,Y., Goldenberg,D., Xiao,C., Fliegauf,M. et al. (2002) The Runx3 transcription factor regulates development and survival of TrkC dorsal root ganglia neurons. EMBO J., 21, 3454-3463.
5. Levanon,D., Brenner,O., Negreanu,V., Bettoun,D., Woolf,E., Eilam,R., Lotem,J., Gat,U., Otto,F., Speck,N. et al. (2001) Spatial and temporal expression pattern of Runx3 (Aml2) and Runx1 (Aml1) indicates non-redundant functions during mouse embryogenesis. Mech. Dev., 109, 413-417.
6. Cai,Z., de Bruijn,M., Ma,X., Dortland,B., Luteijn,T., Downing,R.J. and Dzierzak,E. (2000) Haploinsufficiency of AML1 affects the temporal and spatial generation of hematopoietic stem cells in the mouse embryo. Immunity, 13, 423-431.
7. North,T., Gu,T.L., Stacy,T., Wang,Q., Howard,L., Binder,M., Marin-Padilla,M. and Speck,N.A. (1999) Cbfa2 is required for the formation of intra-aortic hematopoietic clusters. Development, 126, 2563-2575.
8. Okuda,T., van Deursen,J., Hiebert,S.W., Grosveld,G. and Downing,J.R. (1996) AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell, 84, 321-330.
9. Ichikawa,M., Goyama,S., Asai,T., Kawazu,M., Nakagawa,M., Takeshita,M., Chiba,S., Ogawa,S. and Kurokawa,M. (2008) AML1/Runx1 negatively regulates quiescent hematopoietic stem cells in adult hematopoiesis. J. Immunol., 180, 4402-4408.
10. Kurokawa,M. (2006) AML1/Runx1 as a versatile regulator of hematopoiesis: regulation of its function and a role in adult hematopoiesis. Int. J. Hematol., 84, 136-142.
11. Ghozi,M.C., Bernstein,Y., Negreanu,V., Levanon,D. and Groner,Y. (1996) Expression of the human acute myeloid leukemia gene AML1 is regulated by two promoter regions. Proc. Natl Acad. Sci. USA, 93, 1935-1940.
12. Pozner,A., Lotem,J., Xiao,C., Goldenberg,D., Brenner,O., Negreanu,V., Levanon,D. and Groner,Y. (2007) Developmentally regulated promoter-switch transcriptionally controls Runx1 function during embryonic hematopoiesis. BMC Dev. Biol., 7, 84.
13. Telfer,J.C. and Rothenberg,E.V. (2001) Expression and function of a stem cell promoter for the murine CBFalpha2 gene: distinct roles and regulation in natural killer and T cell development. Dev. Biol., 229, 363-382.
14. Telfer,J.C., Hedblom,E.E., Anderson,M.K., Laurent,M.N. and Rothenberg,E.V. (2004) Localization of the domains in Runx transcription factors required for the repression of CD4 in thymocytes. J. Immunol., 172, 4359-4370.
15. Spender,L.C., Cornish,G.H., Sullivan,A. and Farrell,P.J. (2002) Expression of transcription factor AML-2 (RUNX3, CBF(alpha)-3) is induced by Epstein-Barr virus EBNA-2 and correlates with the B-cell activation phenotype. J. Virol., 76, 4919-4927.
16. Spender,L.C., Whiteman,H.J., Karstegl,C.E. and Farrell,P.J. (2005) Transcriptional cross-regulation of RUNX1 by RUNX3 in human B cells. Oncogene, 24, 1873-1881.
17. Brady,G., Whiteman,H.J., Spender,L.C. and Farrell,P.J. (2009) Downregulation of RUNX1 by RUNX3 requires the RUNX3 VWRPY sequence and is essential for Epstein-Barr virus-driven B-cell proliferation. J. Virol., 83, 6909-6916.
18. Ben-Bassat,H., Goldblum,N., Mitrani,S., Goldblum,T., Yoffey,J.M., Cohen,M.M., Bentwich,Z., Ramot,B., Klein,E. and Klein,G. (1977) Establishment in continuous culture of a new type of lymphocyte from a "Burkitt like" malignant lymphoma (line D.G.-75). Int. J. Cancer, 19, 27-33.
19. van Santen,V., Cheung,A., Hummel,M. and Kieff,E. (1983) RNA encoded by the IR1-U2 region of Epstein-Barr virus DNA in latently infected, growth-transformed cells. J. Virol., 46, 424-433.
20. Young,L.S., Lau,R., Rowe,M., Niedobitek,G., Packham,G., Shanahan,F., Rowe,D.T., Greenspan,D., Greenspan,J.S., Rickinson,A.B. et al. (1991) Differentiation-associated expression of the Epstein-Barr virus BZLF1 transactivator protein in oral hairy leukoplakia. J. Virol., 65, 2868-2874.
21. Fujita,Y., Nishimura,M., Taniwaki,M., Abe,T. and Okuda,T. (2001) Identification of an alternatively spliced form of the mouse AML1/RUNX1 gene transcript AML1c and its expression in early hematopoietic development. Biochem. Biophys. Res. Commun., 281, 1248-1255.
22. Cammenga,J., Niebuhr,B., Horn,S., Bergholz,U., Putz,G., Buchholz,F., Lohler,J. and Stocking,C. (2007) RUNX1 DNA-binding mutants, associated with minimally differentiated acute myelogenous leukemia, disrupt myeloid differentiation. Cancer Res., 67, 537-545.
23. Zeng,C., van Wijnen,A.J., Stein,J.L., Meyers,S., Sun,W., Shopland,L., Lawrence,J.B., Penman,S., Lian,J.B., Stein,G.S. et al. (1997) Identification of a nuclear matrix targeting signal in the leukemia and bone-related AML/CBF-alpha transcription factors. Proc. Natl Acad. Sci. USA, 94, 6746-6751.
24. Stifani,S., Blaumueller,C.M., Redhead,N.J., Hill,R.E. and Artavanis-Tsakonas,S. (1992) Human homologs of a Drosophila Enhancer of split gene product define a novel family of nuclear proteins. Nat. Genet., 2, 343.
25. Levanon,D., Goldstein,R.E., Bernstein,Y., Tang,H., Goldenberg,D., Stifani,S., Paroush,Z. and Groner,Y. (1998) Transcriptional repression by AML1 and LEF-1 is mediated by the TLE/Groucho corepressors. Proc. Natl Acad. Sci. USA, 95, 11590-11595.
26. Schwieger,M., Lohler,J., Friel,J., Scheller,M., Horak,I. and Stocking,C. (2002) AML1-ETO inhibits maturation of multiple lymphohematopoietic lineages and induces myeloblast transformation in synergy with ICSBP deficiency. J. Exp. Med., 196, 1227-1240.
27. de Guzman,C.G., Johnson,A. and Klug,C.A. (2003) The ETO domain is necessary for the developmental abnormalities associated with AML1-ETO expression in the hematopoietic stem cell compartment in vivo. Blood Cells Mol. Dis., 30, 201-206.
28. Fenske,T.S., Pengue,G., Mathews,V., Hanson,P.T., Hamm,S.E., Riaz,N. and Graubert,T.A. (2004) Stem cell expression of the AML1/ETO fusion protein induces a myeloproliferative disorder in mice. Proc. Natl Acad. Sci. USA, 101, 15184-15189.
29. Yuan,Y., Zhou,L., Miyamoto,T., Iwasaki,H., Harakawa,N., Hetherington,C.J., Burel,S.A., Lagasse,E., Weissman,I.L., Akashi,K. et al. (2001) AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations. Proc. Natl Acad. Sci. USA, 98, 10398-10403.
30. Dann,E.J., Fears,S., Arad-Dann,H., Nucifora,G. and Rowley,J.D. (2000) Lineage specificity of CBFA2 fusion transcripts. Leuk. Res., 24, 11-17.
31. Morrow,M., Horton,S., Kioussis,D., Brady,H.J. and Williams,O. (2004) TEL-AML1 promotes development of specific hematopoietic lineages consistent with preleukemic activity. Blood, 103, 3890-3896.
32. Kanatani,N., Fujita,T., Fukuyama,R., Liu,W., Yoshida,C.A., Moriishi,T., Yamana,K., Miyazaki,T., Toyosawa,S. and Komori,T. (2006) Cbf beta regulates Runx2 function isoform-dependently in postnatal bone development. Dev. Biol., 296, 48-61.
33. Bravo,J., Li,Z., Speck,N.A. and Warren,A.J. (2001) The leukemia-associated AML1 (Runx1)-CBF beta complex functions as a DNA-induced molecular clamp. Nat. Struct. Biol., 8, 371-378.
34. Huang,G., Shigesada,K., Ito,K., Wee,H.J., Yokomizo,T. and Ito,Y. (2001) Dimerization with PEBP2beta protects RUNX1/AML1 from ubiquitin-proteasome- mediated degradation. EMBO J., 20, 723-733.
35. Tahirov,T.H., Inoue-Bungo,T., Morii,H., Fujikawa,A., Sasaki,M., Kimura,K., Shiina,M., Sato,K., Kumasaka,T., Yamamoto,M. et al. (2001) Structural analyses of DNA recognition by the AML1/Runx-1 Runt domain and its allosteric control by CBFbeta. Cell, 104, 755-767.
36. Koren,E. and Torchilin,V.P. (2012) Cell-penetrating peptides: breaking through to the other side. Trends Mol. Med., 18, 385-393.
37. Lysakova-Devine,T., Keogh,B., Harrington,B., Nagpal,K., Halle,A., Golenbock,D.T., Monie,T. and Bowie,A.G. (2010) Viral inhibitory peptide of TLR4, a peptide derived from vaccinia protein A46, specifically inhibits TLR4 by directly targeting MyD88 adaptor-like and TRIF-related adaptor molecule. J. Immunol., 185, 4261-4271.
38. Strobl,L.J., Hofelmayr,H., Marschall,G., Brielmeier,M., Bornkamm,G.W. and Zimber-Strobl,U. (2000) Activated Notch1 modulates gene expression in B cells similarly to Epstein-Barr viral nuclear antigen 2. J. Virol., 74, 1727-1735.
39. Hofelmayr,H., Strobl,L.J., Marschall,G., Bornkamm,G.W. and Zimber-Strobl,U. (2001) Activated Notch1 can transiently substitute for EBNA2 in the maintenance of proliferation of LMP1-expressing immortalized B cells. J. Virol., 75, 2033-2040.
40. Levanon,D., Bernstein,Y., Negreanu,V., Ghozi,M.C., Bar-Am,I., Aloya,R., Goldenberg,D., Lotem,J. and Groner,Y. (1996) A large variety of alternatively spliced and differentially expressed mRNAs are encoded by the human acute myeloid leukemia gene AML1. DNA Cell Biol., 15, 175-185.
41. Wong,W.F., Nakazato,M., Watanabe,T., Kohu,K., Ogata,T., Yoshida,N., Sotomaru,Y., Ito,M., Araki,K., Telfer,J. et al. (2010) Over-expression of Runx1 transcription factor impairs the development of thymocytes from the double-negative to double-positive stages. Immunology, 130, 243-253.
42. Stewart,M., Terry,A., Hu,M., O'Hara,M., Blyth,K., Baxter,E., Cameron,E., Onions,D.E. and Neil,J.C. (1997) Proviral insertions induce the expression of bone-specific isoforms of PEBP2alphaA (CBFA1): evidence for a new myc collaborating oncogene. Proc. Natl Acad. Sci. USA, 94, 8646-8651.
43. Wotton,S., Stewart,M., Blyth,K., Vaillant,F., Kilbey,A., Neil,J.C. and Cameron,E.R. (2002) Proviral insertion indicates a dominant oncogenic role for Runx1/AML-1 in T-cell lymphoma. Cancer Res., 62, 7181-7185.